Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm
Haematologica, 2009 Acute myeloid leukemia carrying cytoplasmic mutated nucleophosmin (NPMc+ AML) and blastic plasmacytoid dendritic cell neoplasm have been included as new entities in the 4th edition (2008) WHO classification of myeloid neoplasms. These conditions may show
Fabio Facchetti +7 more
doaj +1 more source
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy [PDF]
, 2021 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare aggressive myeloid neoplasm which shows a high rate of central nervous system (CNS) recurrence and overall survival (OS) of
Almeida, Julia +14 more
core +1 more source
Blastic plasmacytoid dendritic cell neoplasm of the uterus [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2020 Introduction. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and very aggressive hematological malignancy derived from precursor of the plasmacytoid dendritic cell.
Đurđević Predrag +8 more
doaj +1 more source
Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis [PDF]
, 2013 Mature natural killer (NK) cell neoplasms are classified by the World Health Organization into NK/T cell lymphoma, nasal type (NKTCL), aggressive NK-cell leukemia (ANKCL) and chronic lymphoproliferative disorders of NK-cells, the latter being considered ...
Lima, M.
core +2 more sources
CT findings associated with blastic plasmacytoid dendritic cell neoplasm: a case report
Acta Radiologica Open, 2016 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that is frequently misdiagnosed. We present a case of a 53-year-old man diagnosed with blastic plasmacytoid dendritic cell neoplasm with extensive computed tomography ...
Daniel Jeong +3 more
doaj +1 more source
Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View. [PDF]
Int J Mol Sciblastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematological malignancy derived from the precursors of plasmacytoid dendritic cells.
Di Raimondo C +6 more
europepmc +3 more sources
Cutaneous lymphoma in Japan: A nationwide study of 1733 patients [PDF]
, 2014 Types of cutaneous lymphoma (CL) and their incidences may vary among geographic areas or ethnic groups. The present study aimed to investigate the incidences of various CL in Japan, using epidemiological data from a nationwide registration system for CL.
Agar +48 more
core +1 more source
Journal of International Medical Research, 2021 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematodermic malignancy derived from plasmacytoid dendritic cell precursors. Despite advances in our understanding of tumor cell surface markers, the pathogenesis of BPDCN remains
Xinmei Dang +3 more
doaj +1 more source
Trafficking properties of plasmacytoid dendritic cells in health and disease. [PDF]
, 2010 Plasmacytoid dendritic cells (PDCs) represent a subset of circulating leukocytes characterized by the ability to release high levels of type I interferon (IFN). Under homeostatic conditions PDCs are confined to primary and secondary lymphoid organs. This
Del Prete A +3 more
core +1 more source
Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1. [PDF]
, 2015 The histiocytoses are rare tumors characterized by the primary accumulation and tissue infiltration of histiocytes and dendritic cells. Identification of the activating BRAFV600E mutation in Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis
Arceci, Robert J +8 more
core +3 more sources